Vimarsana
Biggest News Aggregation in the World

Page 9 - Pharma Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Ltd Today - Breaking & Trending Today

Indices: Stock market update: Nifty Pharma index falls 0.37% in an upbeat market - Vimarsana News

Indices: Stock market update: Nifty Pharma index falls 0.37% in an upbeat market

The Nifty Pharma index was trading 0.37 per cent down at 17282.75.

Indices: Stock market update: Nifty Pharma index falls 0.86% in an upbeat market - Vimarsana News

Indices: Stock market update: Nifty Pharma index falls 0.86% in an upbeat market

The Nifty Pharma index was trading 0.86 per cent down at 17263.6.

Indices: Stock market update: Nifty Pharma index advances 0.61% in a weak market - Vimarsana News

Indices: Stock market update: Nifty Pharma index advances 0.61% in a weak market

The Nifty Pharma index was trading 0.61 per cent up at 17379.8.

Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST - Vimarsana News

Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST

Updated Interim Results for the Six Months Ended 30 June 2023 NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough...

In Wake Of In Re Cellect, District Court Interprets Safe Harbor Statute And Finds Patent Not Invalid For Obviousness-Type Double Patenting - Patent - Vimarsana News

In Wake Of In Re Cellect, District Court Interprets Safe Harbor Statute And Finds Patent Not Invalid For Obviousness-Type Double Patenting - Patent

The requirement that the "divisional application is filed before the issuance of the patent…" is inapplicable when the challenged patent issues from the original application.

Source: mondaq.com